Literature DB >> 194021

Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine.

H Lundh, S Leander, S Thesleff.   

Abstract

The injection of botulinum toxin type A into the hind-leg of adult rats causes complete paralysis of the leg lasting for several weeks. In the extensor digitorum longus (EDL) muscle transmitter release is reduced to a level of less than 1% of normal. Tetraethylammonium (TEA) and guanidine in concentrations of about 3 mM restore, in EDL muslces in vitro, neuromuscular transmission to about the normal level, provided that the external calcium concentration is 4 mM or higher. 4-Aminopyridine (4-AP) has similar restorative effect but is about 20-30 times more potent. Unlike TEA and guanidine, 4-AP is effective when the ambient calcium concentration is 2 mM; this drug is therefore also active in vivo. The intravenous injection of 4-AP (5 mg/kg body weight) restores neuromuscular transmission from complete paralysis by botulinum toxin to a normal level as shown by the recording of almost normal twitch and tetanic tensions in the EDL muscle. In rats paralysed by a lethal dose of botulinum toxin, the intraperitoneal administration of 4-AP restores general motor activity, the effect lasting 1-2 hours. A study of the effects of these drugs on spontaneous and evoked transmitter release suggests that all three compounds increase the level of free calcium inside the nerve terminals. In botulinum poisoning the transmitter release mechanism appears to be intact, but a reduced sensitivity to calcium has been shown (Cull-Candy et al. 1976), and this could explain why the drugs restore evoked transmitter release in botulinum poisoning.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194021     DOI: 10.1016/0022-510x(77)90037-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  43 in total

1.  SNARE proteins contribute to calcium cooperativity of synaptic transmission.

Authors:  B A Stewart; M Mohtashami; W S Trimble; G L Boulianne
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Multiple potassium conductances at the mammalian motor nerve terminal.

Authors:  D A Saint; D M Quastel; Y Y Guan
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

3.  Modulation of stimulation-evoked release of newly formed acetylcholine from mouse hemidiaphragm preparation.

Authors:  G T Somogyi; E S Vizi; I A Chaudhry; H Nagashima; D Duncalf; F F Foldes; P L Goldiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

4.  4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome.

Authors:  H Lundh; O Nilsson; I Rosén
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

5.  Zinc antagonizes the effect of botulinum type A toxin at the mouse neuromuscular junction.

Authors:  M Nishimura; S Kozaki; G Sakaguchi
Journal:  Experientia       Date:  1988-01-15

6.  Reversal of paralysis in nerve-muscle preparations isolated from animals with hereditary motor endplate disease.

Authors:  J B Harris; S L Pollard
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

7.  A comparison of the facilitatory actions of 4-aminopyridine methiodide and 4-aminopyridine on neuromuscular transmission.

Authors:  A S Horn; J J Lambert; I G Marshall
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

8.  Effect of 4-aminopyridine on cardiovascular functions in the dog.

Authors:  E Martínez-Aguirre; J A Wikinski; A Bello; J Izquierdo; A Garcia; H Velarde
Journal:  Can Anaesth Soc J       Date:  1981-03

9.  Stimulation of phrenic nerve activity by an acetylcholine releasing drug: 4-aminopyridine.

Authors:  H Folgering; J Rutten; S Agoston
Journal:  Pflugers Arch       Date:  1979-03-16       Impact factor: 3.657

10.  Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland.

Authors:  A R Wakade
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.